首页  > 

A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge

Xiangchuan He, Longfei Ding, Kangli Cao, Haoran Peng, Chenjian Gu, Yutang Li, Duoduo Li, Lanlan Dong, Xiujing Hong, Xiangwei Wang, Meilan Fu, Chenli Qiu, Cuisong Zhu, Ziling Zhang, Shu Song, Chenguang Wang, Zhengfan Jiang, Youhua Xie, Zhongtian Qi, Chen Zhao, Ping Zhao, Xiaoyan Zhang, Jianqing Xu

Emerg Microbes Infect (IF:13.2) 2021 Dec;10(1):1555-1573. doi: 10.1080/22221751.2021.1957400.

Landscape and Selection of Vaccine Epitopes in SARS-CoV-2

Christof C Smith, Sarah Entwistle, Caryn Willis, Steven Vensko, Wolfgang Beck, Jason Garness, Maria Sambade, Eric Routh, Kelly Olsen, Julia Kodysh, Timothy O'Donnell, Carsten Haber, Kirsten Heiss, Volker Stadler, Erik Garrison, Oliver C Grant, Robert J Woods, Mark Heise, Benjamin G Vincent, Alex Rubinsteyn

bioRxiv (IF:0) 2020 Jun 4;2020.06.04.135004. doi: 10.1101/2020.06.04.135004.

A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection

Tsai-Teng Tzeng #, Kit Man Chai #, Kuan-Yin Shen, Chia-Yi Yu, Shiu-Ju Yang, Wan-Chun Huang, Hung-Chun Liao, Fang-Feng Chiu, Horng-Yunn Dou, Ching-Len Liao, Hsin-Wei Chen, Shih-Jen Liu

NPJ Vaccines (IF:9.2) 2022 Jun 3;7(1):60. doi: 10.1038/s41541-022-00482-0.